98 related articles for article (PubMed ID: 16608394)
1. Gene therapy that safely targets and kills tumor cells throughout the body.
Hurtado A; Tseng JC; Meruelo D
Rejuvenation Res; 2006; 9(1):36-44. PubMed ID: 16608394
[TBL] [Abstract][Full Text] [Related]
2. Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models.
Tseng JC; Hurtado A; Yee H; Levin B; Boivin C; Benet M; Blank SV; Pellicer A; Meruelo D
Cancer Res; 2004 Sep; 64(18):6684-92. PubMed ID: 15374985
[TBL] [Abstract][Full Text] [Related]
3. Sindbis viral vectors target hematopoietic malignant cells.
Suzme R; Tseng JC; Levin B; Ibrahim S; Meruelo D; Pellicer A
Cancer Gene Ther; 2012 Nov; 19(11):757-66. PubMed ID: 22956041
[TBL] [Abstract][Full Text] [Related]
4. Systemic tumor targeting and killing by Sindbis viral vectors.
Tseng JC; Levin B; Hurtado A; Yee H; Perez de Castro I; Jimenez M; Shamamian P; Jin R; Novick RP; Pellicer A; Meruelo D
Nat Biotechnol; 2004 Jan; 22(1):70-7. PubMed ID: 14647305
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
[TBL] [Abstract][Full Text] [Related]
7. In vivo antitumor activity of Sindbis viral vectors.
Tseng JC; Levin B; Hirano T; Yee H; Pampeno C; Meruelo D
J Natl Cancer Inst; 2002 Dec; 94(23):1790-802. PubMed ID: 12464651
[TBL] [Abstract][Full Text] [Related]
8. Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor.
Tseng JC; Granot T; DiGiacomo V; Levin B; Meruelo D
Cancer Gene Ther; 2010 Apr; 17(4):244-55. PubMed ID: 19798121
[TBL] [Abstract][Full Text] [Related]
9. Restricted tissue tropism and acquired resistance to Sindbis viral vector expression in the absence of innate and adaptive immunity.
Tseng JC; Zheng Y; Yee H; Levy DE; Meruelo D
Gene Ther; 2007 Aug; 14(15):1166-74. PubMed ID: 17508007
[TBL] [Abstract][Full Text] [Related]
10. Identification of amino acids of Sindbis virus E2 protein involved in targeting tumor metastases in vivo.
Hurtado A; Tseng JC; Boivin C; Levin B; Yee H; Pampeno C; Meruelo D
Mol Ther; 2005 Nov; 12(5):813-23. PubMed ID: 16109508
[TBL] [Abstract][Full Text] [Related]
11. Controlled propagation of replication-competent Sindbis viral vector using suicide gene strategy.
Tseng JC; Daniels G; Meruelo D
Gene Ther; 2009 Feb; 16(2):291-6. PubMed ID: 18818670
[TBL] [Abstract][Full Text] [Related]
12. Sindbis virus--an effective targeted cancer therapeutic.
Hay JG
Trends Biotechnol; 2004 Oct; 22(10):501-3. PubMed ID: 15450742
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific targeting with modified Sindbis viral vectors: evaluation with optical imaging and positron emission tomography in vivo.
Stelter L; Tseng JC; Torosjan A; Levin B; Longo VA; Pillarsetty N; Zanzonico P; Meruelo D; Larson SM
Mol Imaging Biol; 2013 Apr; 15(2):166-74. PubMed ID: 22847302
[TBL] [Abstract][Full Text] [Related]
14. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
Yamanaka R; Xanthopoulos KG
DNA Cell Biol; 2005 May; 24(5):317-24. PubMed ID: 15869409
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for acute myeloid leukemia using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Tan L; Xu B; Liu R; Liu H; Tan H; Huang W
Cancer Biol Ther; 2010 Mar; 9(5):350-7. PubMed ID: 20061812
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic viral therapy for cervical and ovarian cancer cells by Sindbis virus AR339 strain.
Unno Y; Shino Y; Kondo F; Igarashi N; Wang G; Shimura R; Yamaguchi T; Asano T; Saisho H; Sekiya S; Shirasawa H
Clin Cancer Res; 2005 Jun; 11(12):4553-60. PubMed ID: 15958641
[TBL] [Abstract][Full Text] [Related]
17. Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system.
Altman-Hamamdzic S; Groseclose C; Ma JX; Hamamdzic D; Vrindavanam NS; Middaugh LD; Parratto NP; Sallee FR
Gene Ther; 1997 Aug; 4(8):815-22. PubMed ID: 9338010
[TBL] [Abstract][Full Text] [Related]
18. Recombination of replicon and helper RNAs and the emergence of propagation-competent vectors upon Sindbis virus vector production.
Hyvärinen A; Yongabi F; Mäkinen K; Wahlfors J; Pellinen R
Int J Mol Med; 2013 Aug; 32(2):410-22. PubMed ID: 23716190
[TBL] [Abstract][Full Text] [Related]
19. Development of improved Sindbis virus-based DNA expression vector.
Yamanaka R; Xanthopoulos KG
DNA Cell Biol; 2004 Feb; 23(2):75-80. PubMed ID: 15000747
[TBL] [Abstract][Full Text] [Related]
20. Suppression of ovarian cancer by muscle-mediated expression of soluble VEGFR-1/Flt-1 using adeno-associated virus serotype 1-derived vector.
Takei Y; Mizukami H; Saga Y; Yoshimura I; Hasumi Y; Takayama T; Kohno T; Matsushita T; Okada T; Kume A; Suzuki M; Ozawa K
Int J Cancer; 2007 Jan; 120(2):278-84. PubMed ID: 17066424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
